ARTICLE | Distillery Therapeutics
Cancer
March 20, 2018 11:11 PM UTC
Cell culture and mouse studies suggest inhibition of SRF or its co-activator MLK1 could help treat drug-resistant BCC. In one human and two mouse SMO inhibitor-resistant BCC cell lines, a tool compoun...